{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:59:34Z","timestamp":1792155574318,"version":"4.4.0"},"reference-count":172,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603041"],"award-info":[{"award-number":["81603041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.apsb.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T18:17:40Z","timestamp":1623953860000},"page":"2396-2415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-0433","authenticated-orcid":false,"given":"Yujie","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakia","family":"Belhadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.05.002_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/COH.0000000000000591","article-title":"Long-acting implants to treat and prevent HIV infection","volume":"15","author":"Weld","year":"2020","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.apsb.2021.05.002_bib2","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/S2352-3018(19)30342-X","article-title":"Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV","volume":"7","author":"Bollinger","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.apsb.2021.05.002_bib3","doi-asserted-by":"crossref","first-page":"11987","DOI":"10.1073\/pnas.2004746117","article-title":"Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine","volume":"117","author":"Verma","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.05.002_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/JCP.0000000000001225","article-title":"Persistent barriers to the use of long-acting injectable antipsychotics for the treatment of schizophrenia","volume":"40","author":"Lindenmayer","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.apsb.2021.05.002_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.64719\/pb.4361","article-title":"Long-acting injectable paliperidone palmitate: a review of efficacy and safety","volume":"47","author":"Morris","year":"2017","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.apsb.2021.05.002_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2020.04.012","article-title":"Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosanzinc-insulin complexes incorporated in thermosensitive copolymer","volume":"323","author":"Sharma","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/CRD.0000000000000266","article-title":"Long-acting basal insulins: a review of the more recently approved agents","volume":"27","author":"Gallegos Aragon","year":"2019","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.apsb.2021.05.002_bib8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/pedi.13069","article-title":"Long-acting contraception in adolescents and young women with type 1 and type 2 diabetes","volume":"21","author":"Salinas","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.apsb.2021.05.002_bib9","first-page":"749","article-title":"Long-acting hormonal contraception","volume":"11","author":"Benagiano","year":"2015","journal-title":"Womens Health"},{"key":"10.1016\/j.apsb.2021.05.002_bib10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0015-0282(98)00015-6","article-title":"Ovarian function during the use of a single contraceptive implant: implanon compared with Norplant","volume":"69","author":"M\u00e4k\u00e4r\u00e4inen","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.apsb.2021.05.002_bib11","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.05.002_bib12","first-page":"111","article-title":"Pharmacokinetics and biodistribution of pegylated methotrexate after iv administration to mice","volume":"17","author":"Yousefi","year":"2018","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib13","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/acsnano.9b01710","article-title":"Secreted protein acidic and rich in cysteine mediated biomimetic delivery of methotrexate by albumin-based nanomedicines for rheumatoid arthritis therapy","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib14","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1208\/s12249-017-0762-9","article-title":"Development of\u00a0albumin coupled, cholesterol stabilized, lipid nanoemulsion of\u00a0methotrexate, and TNF-alpha inhibitor for improved in\u00a0vivo efficacy against rheumatoid arthritis","volume":"18","author":"Li","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2021.05.002_bib15","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.2147\/IJN.S109547","article-title":"The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate","volume":"11","author":"Zhang","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2021.05.002_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.msec.2015.12.015","article-title":"Vincristine sulfate loaded dextran microspheres amalgamated with thermosensitive gel offered sustained release and enhanced cytotoxicity in THP-1, human leukemia cells: in\u00a0vitro and in\u00a0vivo study","volume":"61","author":"Thakur","year":"2016","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.apsb.2021.05.002_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/protein\/gzt023","article-title":"PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins","volume":"26","author":"Schlapschy","year":"2013","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.apsb.2021.05.002_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeut"},{"key":"10.1016\/j.apsb.2021.05.002_bib19","doi-asserted-by":"crossref","first-page":"108750","DOI":"10.1016\/j.biopha.2019.108750","article-title":"Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment","volume":"113","author":"AlQahtani","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2021.05.002_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2020.11.008","article-title":"Clinically established biodegradable long acting injectables: an industry perspective","volume":"167","author":"Nkanga","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2021.05.002_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2020.05.013","article-title":"Three significant highlights of controlled drug delivery over the past 55 years: PEGylation, ADCs, and EPR","volume":"158","author":"Hoffman","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2021.05.002_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2021.05.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2016.05.029","article-title":"The early days of PEG and PEGylation (1970s\u20121990s)","volume":"40","author":"Hoffman","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2021.05.002_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2017.01.029","article-title":"Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone","volume":"249","author":"Wu","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbpa.2016.08.006","article-title":"How PEGylation influences protein conformational stability","volume":"34","author":"Lawrence","year":"2016","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apsb.2021.05.002_bib26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u02b9Souza","year":"2016","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2021.05.002_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biomaterials.2016.11.033","article-title":"Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: turning PEG dilemma into prodrug-like feature","volume":"116","author":"Chen","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C8NH00417J","article-title":"DePEGylation strategies to increase cancer nanomedicine efficacy","volume":"4","author":"Kong","year":"2019","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.apsb.2021.05.002_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2021.05.002_bib30","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1021\/acs.nanolett.9b00737","article-title":"Light-triggered PEGylation\/dePEGylation of the nanocarriers for enhanced tumor penetration","volume":"19","author":"Zhou","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2021.05.002_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpharm.2018.07.009","article-title":"Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes","volume":"548","author":"Kanamala","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EC-17-0007","article-title":"A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency","volume":"6","author":"Hoybye","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.apsb.2021.05.002_bib33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2016-3776","article-title":"A randomized phase 2 study of long-acting TransCon GH vs daily GH in childhood GH deficiency","volume":"102","author":"Chatelain","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2021.05.002_bib34","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.3824","article-title":"Design and preclinical development of transcon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism","volume":"34","author":"Holten-Andersen","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib35","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/jbmr.4016","article-title":"A randomized double-blind placebo-controlled first-in-human phase 1 trial of TransCon PTH in healthy adults","volume":"35","author":"Karpf","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201904716","article-title":"Poly(sarcosine) surface modification imparts stealth-like properties to liposomes","volume":"15","author":"Bleher","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.apsb.2021.05.002_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2016.05.010","article-title":"Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance","volume":"234","author":"Shiraishi","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","article-title":"Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials","volume":"124","author":"Khutoryanskiy","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2021.05.002_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/polym12020298","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2021.05.002_bib41","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1021\/acs.molpharmaceut.8b00292","article-title":"Bioinspired shielding strategies for nanoparticle drug delivery applications","volume":"15","author":"Gulati","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib42","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/bc800242t","article-title":"Poly(2-methacryloyloxyethyl phosphorylcholine) for protein conjugation","volume":"19","author":"Lewis","year":"2008","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.apsb.2021.05.002_bib43","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.apsb.2021.05.002_bib44","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2021.05.002_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/1872211312666180717164758","article-title":"Clinical application of polysialylated deoxyribonuclease and erythropoietin","volume":"12","author":"Meng","year":"2018","journal-title":"Recent Pat Drug Deliv Formulation"},{"key":"10.1016\/j.apsb.2021.05.002_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol Cell Ther"},{"key":"10.1016\/j.apsb.2021.05.002_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","article-title":"Biomacromolecules as carriers in drug delivery and tissue engineering","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.05.002_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.12782","article-title":"Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes","volume":"19","author":"Heise","year":"2017","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.apsb.2021.05.002_bib49","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1742-1241.2010.02470.x","article-title":"How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes","volume":"64","author":"Arnolds","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.apsb.2021.05.002_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic oligonucleotides: state of the art","volume":"59","author":"Smith","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2021.05.002_bib51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/med.21479","article-title":"Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy","volume":"38","author":"Chen","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2021.05.002_bib52","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib53","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.05.002_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacl.2019.11.001","article-title":"Inclisiran-new hope in the management of lipid disorders?","volume":"14","author":"Dyrbus","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.apsb.2021.05.002_bib55","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1093\/nar\/gkaa670","article-title":"Investigating the pharmacodynamic durability of GalNAc-siRNA conjugates","volume":"48","author":"Brown","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jssc.202000765","article-title":"Therapeutic Fc-fusion proteins: current analytical strategies","volume":"44","author":"Duivelshof","year":"2020","journal-title":"J Separ Sci"},{"key":"10.1016\/j.apsb.2021.05.002_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2021.05.002_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/19420862.2017.1388483","article-title":"Manufacturing history of etanercept (Enbrel\u00ae): consistency of product quality through major process revisions","volume":"10","author":"Hassett","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.apsb.2021.05.002_bib59","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s40265-014-0258-9","article-title":"Etanercept: a review of its use in autoimmune inflammatory diseases","volume":"74","author":"Scott","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2021.05.002_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tibtech.2014.11.001","article-title":"Fc fusion as a platform technology: potential for modulating immunogenicity","volume":"33","author":"Levin","year":"2015","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.apsb.2021.05.002_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07388551.2013.834293","article-title":"Fc-fusion proteins and FcRn: structural insights for longer-lasting and\u00a0more effective therapeutics","volume":"35","author":"Rath","year":"2015","journal-title":"Crit Rev Biotechnol"},{"key":"10.1016\/j.apsb.2021.05.002_bib62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/19420862.2015.1113360","article-title":"Pharmacokinetic properties of IgG and various Fc fusion proteins in mice","volume":"8","author":"Unverdorben","year":"2016","journal-title":"mAbs"},{"issue":"Suppl 1","key":"10.1016\/j.apsb.2021.05.002_bib63","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1111\/jth.12929","article-title":"Half-life extended factor VIII for the treatment of hemophilia A","volume":"13","author":"Tiede","year":"2015","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.apsb.2021.05.002_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biomaterials.2016.11.051","article-title":"Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery","volume":"117","author":"Zhou","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib65","doi-asserted-by":"crossref","first-page":"173650","DOI":"10.1016\/j.ejphar.2020.173650","article-title":"Albumin-binding domain extends half-life of glucagon-like peptide-1","volume":"890","author":"Tan","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.002_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery\u2014new applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2018.07.023","article-title":"Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement","volume":"287","author":"Larsen","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01781-20","article-title":"Engineering of long-circulating peptidoglycan hydrolases enables efficient treatment of systemic Staphylococcus aureus infection","volume":"11","author":"Sobieraj","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2021.05.002_bib69","doi-asserted-by":"crossref","first-page":"17405","DOI":"10.1021\/acsnano.0c07610","article-title":"Bioengineered human serum albumin fusion protein as target\/enzyme\/pH three-stage propulsive drug vehicle for tumor therapy","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5483\/BMBRep.2013.46.12.106","article-title":"Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes","volume":"46","author":"Kim","year":"2013","journal-title":"BMB Rep"},{"key":"10.1016\/j.apsb.2021.05.002_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40265-016-0679-8","article-title":"Coagulation factor IX (recombinant), albumin fusion protein (albutrepenonacog alfa; Idelvion\u00ae): a review of its use in haemophilia B","volume":"77","author":"Lyseng-Williamson","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2021.05.002_bib72","doi-asserted-by":"crossref","first-page":"120250","DOI":"10.1016\/j.biomaterials.2020.120250","article-title":"Genetic engineering of novel super long-acting exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity","volume":"257","author":"Lee","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2021.05.002_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9250","article-title":"Erythrocyte leveraged chemotherapy (ELeCt): nanoparticle assembly on erythrocyte surface to combat lung metastasis","volume":"5","author":"Zhao","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2021.05.002_bib75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting strategies for tissue-specific drug delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.05.002_bib76","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41551-020-00644-2","article-title":"Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases","volume":"5","author":"Zhao","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2021.05.002_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2017.01.048","article-title":"Cell-mediated delivery of synthetic nano- and microparticles","volume":"259","author":"Ayer","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib78","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acs.accounts.7b00526","article-title":"Leveraging engineering of cells for drug delivery","volume":"51","author":"Chen","year":"2018","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib79","article-title":"Biomimetic diselenide-bridged mesoporous organosilica nanoparticles as an X-ray-responsive biodegradable carrier for chemo-immunotherapy","volume":"32","author":"Shao","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib80","doi-asserted-by":"crossref","first-page":"120084","DOI":"10.1016\/j.ijpharm.2020.120084","article-title":"Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K1","volume":"592","author":"Wang","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib81","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/j.biomaterials.2010.01.021","article-title":"Adsorption of amphiphilic hyperbranched polyglycerol derivatives onto human red blood cells","volume":"31","author":"Liu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib82","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib83","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.actbio.2020.11.049","article-title":"Polymeric micelles coated with hybrid nanovesicles enhance the therapeutic potential of the reversible topoisomerase inhibitor camptothecin in a mouse model","volume":"121","author":"Malhotra","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2021.05.002_bib84","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.05.002_bib85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","article-title":"Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u02b9s disease mice","volume":"108","author":"Gao","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2021.05.002_bib86","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1016\/j.biomaterials.2012.04.051","article-title":"Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces","volume":"33","author":"Finley","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib87","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1039\/C9BM01392J","article-title":"Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2021.05.002_bib88","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib89","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s40265-014-0283-8","article-title":"Octreotide long-acting release (LAR): a review of its use in the management of acromegaly","volume":"74","author":"Burness","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2021.05.002_bib90","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jconrel.2020.10.044","article-title":"Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles","volume":"329","author":"Park","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v12.i1.10","article-title":"Biodegradable microspheres in drug delivery","volume":"12","author":"Okada","year":"1995","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.apsb.2021.05.002_bib92","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/acs.molpharmaceut.9b01188","article-title":"Effect of manufacturing variables and raw materials on the composition-equivalent PLGA microspheres for 1-month controlled release of leuprolide","volume":"17","author":"Zhou","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40265-019-01083-3","article-title":"Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee","volume":"79","author":"Paik","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2021.05.002_bib94","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.msec.2016.02.038","article-title":"Material characterization of microsphere-based scaffolds with encapsulated raw materials","volume":"63","author":"Sridharan","year":"2016","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.apsb.2021.05.002_bib95","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/02652049809008253","article-title":"Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues","volume":"15","author":"Crotts","year":"1998","journal-title":"J Microencapsul"},{"key":"10.1016\/j.apsb.2021.05.002_bib96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(03)00194-9","article-title":"Biodegradable microspheres for protein delivery","volume":"90","author":"Sinha","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib97","doi-asserted-by":"crossref","first-page":"120220","DOI":"10.1016\/j.ijpharm.2021.120220","article-title":"Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: monolithic dispersions studied at lower temperatures","volume":"596","author":"Tamani","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib98","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2016.08.032","article-title":"Towards a better understanding of the different release phases from PLGA microparticles: dexamethasone-loaded systems","volume":"514","author":"Gasmi","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2021.05.002_bib100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib101","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0163-7827(02)00004-8","article-title":"A lipid based depot (DepoFoam technology) for sustained release drug delivery","volume":"41","author":"Mantripragada","year":"2002","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14656566.9.2.301","article-title":"Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments","volume":"9","author":"Benesch","year":"2008","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.apsb.2021.05.002_bib103","first-page":"9","article-title":"Multivesicular liposome (Depofoam) in human diseases","volume":"19","author":"Salehi","year":"2020","journal-title":"Iran J Pharm Res (IJPR)"},{"key":"10.1016\/j.apsb.2021.05.002_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.12.030","article-title":"Vesicular phospholipid gels as drug delivery systems for small molecular weight drugs, peptides and proteins: state of the art review","volume":"557","author":"Breitsamer","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s11671-019-3241-2","article-title":"Advances of nano-structured extended-release local anesthetics","volume":"15","author":"He","year":"2020","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.apsb.2021.05.002_bib106","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/SCS.0000000000004312","article-title":"Extended release liposomal bupivacaine injection (Exparel) for early postoperative pain control following pharyngoplasty","volume":"29","author":"Day","year":"2018","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.apsb.2021.05.002_bib107","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/bdd.2088","article-title":"Pharmacokinetics of dinalbuphine sebacate and nalbuphine in human after intramuscular injection of dinalbuphine sebacate in an extended-release formulation","volume":"38","author":"Tien","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.apsb.2021.05.002_bib108","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/pharmaceutics12060567","article-title":"Injectable lipid-based depot formulations: where do we stand?","volume":"12","author":"Rahnfeld","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2021.05.002_bib109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1017\/S1092852918000895","article-title":"Converting oral to long-acting injectable antipsychotics: a guide for the perplexed\u2014CORRIGENDUM","volume":"23","author":"Meyer","year":"2018","journal-title":"CNS Spectr"},{"key":"10.1016\/j.apsb.2021.05.002_bib110","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1208\/s12248-009-9153-9","article-title":"Critical factors influencing the in\u00a0vivo performance of long-acting lipophilic solutions\u2014impact on in\u00a0vitro release method design","volume":"11","author":"Weng Larsen","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.apsb.2021.05.002_bib111","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.02.045","article-title":"Drug nanocrystals: fabrication methods and promising therapeutic applications","volume":"562","author":"Mohammad","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.030","article-title":"Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery","volume":"183","author":"Pawar","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib113","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1586\/ern.12.137","article-title":"A review of paliperidone palmitate","volume":"12","author":"Chue","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.apsb.2021.05.002_bib114","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/1061186X.2017.1419363","article-title":"Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook","volume":"26","author":"Mu","year":"2018","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2021.05.002_bib115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/17512433.2016.1191945","article-title":"Three-month paliperidone palmitate\u2014a new treatment option for schizophrenia","volume":"9","author":"Bernardo","year":"2016","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.002_bib116","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2020.05.022","article-title":"Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs","volume":"324","author":"Surve","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib117","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2018.02.003","article-title":"Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation","volume":"275","author":"Kraft","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib118","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01529-09","article-title":"Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation","volume":"54","author":"van't Klooster","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.05.002_bib119","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2174\/0929867321666140826114135","article-title":"Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies","volume":"21","author":"Edagwa","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2021.05.002_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201605903","article-title":"Biomineralization: from material tactics to biological strategy","volume":"29","author":"Yao","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib121","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/cm0212156","article-title":"Organic\u2212inorganic hybrid structure of calcite crystalline assemblies grown in a gelatin hydrogel matrix:\u2009 relevance to biomineralization","volume":"14","author":"Grassmann","year":"2002","journal-title":"Chem Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib122","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1021\/acsnano.7b01809","article-title":"Long-acting release formulation of exendin-4 based on biomimetic mineralization for type 2 diabetes therapy","volume":"11","author":"Chen","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib123","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2016.10.013","article-title":"Design and fabrication of hydrogel-based nanoparticulate systems for in vivo drug delivery","volume":"243","author":"Lai","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib124","article-title":"Recent progress in the design and application of supramolecular peptide hydrogels in cancer therapy","volume":"10","author":"Cai","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201604062","article-title":"Amino acids and peptide-based supramolecular hydrogels for three-dimensional cell culture","volume":"29","author":"Dou","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib126","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1021\/acs.biomac.0c00989","article-title":"On the mechanism of self-assembly by a hydrogel-forming peptide","volume":"21","author":"Braun","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2021.05.002_bib127","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.1021\/acsnano.8b04143","article-title":"Tandem enzymatic self-assembly and slow release of dexamethasone enhances its antihepatic fibrosis effect","volume":"12","author":"Tang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib128","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1039\/C7CC09365A","article-title":"Alkaline phosphatase-triggered assembly of etoposide enhances its anticancer effect","volume":"54","author":"Kiran","year":"2018","journal-title":"Chem Commun"},{"key":"10.1016\/j.apsb.2021.05.002_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805018","article-title":"Immune responsive release of tacrolimus to overcome organ transplant rejection","volume":"30","author":"Wu","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib130","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1021\/acsnano.9b00788","article-title":"Sustained\u00a0release of two bioactive factors from supramolecular hydrogel promotes periodontal bone regeneration","volume":"13","author":"Tan","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib131","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41467-019-09601-3","article-title":"Directed self-assembly of herbal small molecules into sustained release hydrogels\u00a0for treating neural inflammation","volume":"10","author":"Zheng","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.05.002_bib132","doi-asserted-by":"crossref","first-page":"120403","DOI":"10.1016\/j.biomaterials.2020.120403","article-title":"A pure molecular drug hydrogel for post-surgical cancer treatment","volume":"265","author":"Qian","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib133","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1021\/acsnano.9b01346","article-title":"Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2021.05.002_bib134","doi-asserted-by":"crossref","first-page":"44210","DOI":"10.1038\/srep44210","article-title":"A glycyrrhetinic acid-modified curcumin supramolecular hydrogel for liver tumor targeting therapy","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.05.002_bib135","doi-asserted-by":"crossref","first-page":"15342","DOI":"10.1002\/anie.201907670","article-title":"Stimuli-responsive biomolecule-based hydrogels and their applications","volume":"59","author":"Vazquez-Gonzalez","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2021.05.002_bib136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2019.01.026","article-title":"Injectable thermosensitive hydrogel systems based on functional PEG\/PCL block polymer for local drug delivery","volume":"297","author":"Deng","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib137","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.2147\/IJN.S248987","article-title":"Smart hydrogels\u2014synthetic stimuli-responsive antitumor drug release systems","volume":"15","author":"Kasinski","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2021.05.002_bib138","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acs.accounts.6b00581","article-title":"Bioresponsive DNA hydrogels: beyond the conventional stimuli responsiveness","volume":"50","author":"Wang","year":"2017","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib139","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biomaterials.2018.03.023","article-title":"Novel angiogenesis therapeutics by redox injectable hydrogel\u2014regulation of local nitric oxide generation for effective cardiovascular therapy","volume":"167","author":"Vong","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib140","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1038\/s41467-020-18493-7","article-title":"Controllable gelation of artificial extracellular matrix for altering mass transport and improving cancer therapies","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.05.002_bib141","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.drudis.2020.05.006","article-title":"Long-acting microneedles: a progress report of the state-of-the-art techniques","volume":"25","author":"Chen","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.05.002_bib142","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2020.06.039","article-title":"Nanoparticles-encapsulated polymeric microneedles for transdermal drug delivery","volume":"325","author":"Chen","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib143","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1039\/D0TB02279A","article-title":"Design of biodegradable bi-compartmental microneedles for the stabilization and the controlled release of the labile molecule collagenase for skin healthcare","volume":"9","author":"Di Natale","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2021.05.002_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801054","article-title":"Biodegradable gelatin methacryloyl microneedles for transdermal drug delivery","volume":"8","author":"Luo","year":"2019","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41551-018-0337-4","article-title":"Rapidly separable microneedle patch for the sustained release of a contraceptive","volume":"3","author":"Li","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2021.05.002_bib146","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.biomaterials.2012.03.056","article-title":"Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres","volume":"33","author":"Ke","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2021.05.002_bib147","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw8145","article-title":"Long-acting reversible contraception by effervescent microneedle patch","volume":"5","author":"Li","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2021.05.002_bib148","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.scib.2019.06.016","article-title":"Bio-inspired clamping microneedle arrays from flexible ferrofluid-configured moldings","volume":"64","author":"Zhang","year":"2019","journal-title":"Sci Bull"},{"key":"10.1016\/j.apsb.2021.05.002_bib149","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2017.03.041","article-title":"A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin","volume":"265","author":"Seong","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909197","article-title":"4D printing of a bioinspired microneedle array with backward\u2014facing barbs for enhanced tissue adhesion","volume":"30","author":"Han","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib151","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1002\/adfm.201200864","article-title":"Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery","volume":"22","author":"Donnelly","year":"2012","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2021.05.002_bib152","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actbio.2020.12.004","article-title":"Microneedle-mediated transdermal drug delivery for treating diverse skin diseases","volume":"121","author":"Yang","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2021.05.002_bib153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10544-019-0389-6","article-title":"Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases","volume":"21","author":"Pons-Faudoa","year":"2019","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.apsb.2021.05.002_bib154","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/polym10121379","article-title":"Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications","volume":"10","author":"Stewart","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2021.05.002_bib155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2012.04.016","article-title":"In situ forming implants\u2014an attractive formulation principle for parenteral depot formulations","volume":"161","author":"Kempe","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib156","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","article-title":"PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release","volume":"172","author":"Parent","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib157","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.drudis.2013.01.013","article-title":"Injectable implants for the sustained release of protein and peptide drugs","volume":"18","author":"Agarwal","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.05.002_bib158","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2004.03.003","article-title":"In situ forming parenteral drug delivery systems: an overview","volume":"58","author":"Packhaeuser","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2021.05.002_bib159","doi-asserted-by":"crossref","first-page":"122ra21","DOI":"10.1126\/scitranslmed.3003276","article-title":"First-in-human testing of a wirelessly controlled drug delivery microchip","volume":"4","author":"Farra","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.05.002_bib160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2018.06.035","article-title":"Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer","volume":"285","author":"Chua","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2021.05.002_bib161","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.apsb.2021.05.002_bib162","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11926-010-0093-2","article-title":"New agents for the treatment of gout and hyperuricemia: Febuxostat, puricase, and beyond","volume":"12","author":"Schlesinger","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.apsb.2021.05.002_bib163","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1634\/theoncologist.2012-0123","article-title":"U.S. Food and Drug Administration approval: peginterferon-alfa-2b for the adjuvant treatment of patients with melanoma","volume":"17","author":"Herndon","year":"2012","journal-title":"Oncol"},{"key":"10.1016\/j.apsb.2021.05.002_bib164","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-16-0905","article-title":"Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies","volume":"177","author":"Luo","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.apsb.2021.05.002_bib165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14728214.2019.1604684","article-title":"Emerging PEGylated non-biologic drugs","volume":"24","author":"Park","year":"2019","journal-title":"Expet Opin Emerg Drugs"},{"key":"10.1016\/j.apsb.2021.05.002_bib166","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cei.13420","article-title":"Comparison of elapegademase and pegademase in ADA-deficient patients and mice","volume":"200","author":"Murguia-Favela","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.apsb.2021.05.002_bib167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1158\/1078-0432.CCR-19-2975","article-title":"Space for calaspargase? A new asparaginase for acute lymphoblastic leukemia","volume":"26","author":"Lew","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4174\/astr.2021.100.2.59","article-title":"Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel\u2013cyclophosphamide chemotherapy","volume":"100","author":"Jeon","year":"2021","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.apsb.2021.05.002_bib169","doi-asserted-by":"crossref","first-page":"142906","DOI":"10.1172\/JCI142906","article-title":"B cell activating factor modulates the factor VIII immune response in hemophilia A","volume":"131","author":"Doshi","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2021.05.002_bib170","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/14712598.2016.1165661","article-title":"Half-life extended biotherapeutics","volume":"16","author":"Kontermann","year":"2016","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.apsb.2021.05.002_bib171","doi-asserted-by":"crossref","first-page":"114432","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: updated clinical studies","volume":"189","author":"Zhang","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.002_bib172","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17474086.2021.1893689","article-title":"Recent advances in surgery and its perioperative treatment in people with hemophilia","volume":"14","author":"Rodr\u00edguez-Merch\u00e1n","year":"2021","journal-title":"Expet Rev Hematol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521001672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521001672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:50:36Z","timestamp":1761929436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521001672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":172,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2211383521001672"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.05.002","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}